Repligen
RGEN
#2039
Rank
โ‚น838.39 B
Marketcap
โ‚น14,894
Share price
-0.46%
Change (1 day)
17.94%
Change (1 year)
Categories

Market capitalization of Repligen (RGEN)

Market cap: โ‚น838.39 Billion

As of December 2025 Repligen has a market cap of โ‚น838.39 Billion. This makes Repligen the world's 2039th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Repligen from 1996 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น838.39 B19.85%
2024โ‚น699.51 B-16.3%
2023โ‚น835.70 B7.43%
2022โ‚น777.91 B-28.62%
2021โ‚น1.089 T42.12%
2020โ‚น766.84 B123.23%
2019โ‚น343.52 B112.11%
2018โ‚น161.95 B60.48%
2017โ‚น100.91 B42.43%
2016โ‚น70.85 B14.39%
2015โ‚น61.94 B50.62%
2014โ‚น41.12 B52.87%
2013โ‚น26.90 B150.81%
2012โ‚น10.72 B90.25%
2011โ‚น5.63 B-12.86%
2010โ‚น6.47 B10.29%
2009โ‚น5.86 B3.54%
2008โ‚น5.66 B-29.03%
2007โ‚น7.98 B111.1%
2006โ‚น3.78 B-30.23%
2005โ‚น5.42 B44.5%
2004โ‚น3.75 B-37.03%
2003โ‚น5.95 B49.46%
2002โ‚น3.98 B27.27%
2001โ‚น3.13 B-25.22%
2000โ‚น4.18 B38.09%
1999โ‚น3.03 B209.27%
1998โ‚น0.98 B77.46%
1997โ‚น0.55 B-18.65%
1996โ‚น0.67 B

End of Day market cap according to different sources

On Dec 4th, 2025 the market cap of Repligen was reported to be:

โ‚น838.39 Billion
by Nasdaq info icon info icon
โ‚น838.39 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novavax
NVAX
โ‚น100.16 B-88.05%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น929.04 B 10.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚น1.381 T 64.79%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
โ‚น27.809 T 3,216.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
โ‚น19.419 T 2,216.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น9.502 T 1,033.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น13.129 T 1,466.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
โ‚น889.57 B 6.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
โ‚น16.02 B-98.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
โ‚น813.85 B-2.93%๐Ÿ‡บ๐Ÿ‡ธ USA